You just read:

MicuRx Initiates Phase 3 Clinical Trial for MRX-I, A New Potent Oral Antibiotic Against Gram-positive Bacteria, Including MRSA

News provided by

MicuRx Pharmaceuticals, Inc.

20 Oct, 2016, 08:00 ET